These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 27926659

  • 21. Prolactinoma and pregnancy: From the wish of conception to lactation.
    Maiter D.
    Ann Endocrinol (Paris); 2016 Jun; 77(2):128-34. PubMed ID: 27130071
    [Abstract] [Full Text] [Related]

  • 22. [Treatment of macroprolactinoma with cabergoline during pregnancy].
    Forsbach-Sánchez G, Tamez-Pérez HE, Hernández-Herrera R, Bafidis-Lechuga B.
    Rev Med Inst Mex Seguro Soc; 2009 Jun; 47(3):307-10. PubMed ID: 20141661
    [Abstract] [Full Text] [Related]

  • 23. Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function.
    Sibal L, Ugwu P, Kendall-Taylor P, Ball SG, James RA, Pearce SH, Hall K, Quinton R.
    Pituitary; 2002 Jun; 5(4):243-6. PubMed ID: 14558672
    [Abstract] [Full Text] [Related]

  • 24. Prolactinomas and pregnancy.
    Molitch ME.
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):147-8. PubMed ID: 20550542
    [No Abstract] [Full Text] [Related]

  • 25. Visual loss in pregnant women with pituitary adenomas.
    Kupersmith MJ, Rosenberg C, Kleinberg D.
    Ann Intern Med; 1994 Oct 01; 121(7):473-7. PubMed ID: 8067644
    [Abstract] [Full Text] [Related]

  • 26. An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists.
    O'Sullivan SM, Farrant MT, Ogilvie CM, Gunn AJ, Milsom SR.
    Aust N Z J Obstet Gynaecol; 2020 Jun 01; 60(3):405-411. PubMed ID: 31583693
    [Abstract] [Full Text] [Related]

  • 27. [Prolactin adenomas in Dakar].
    Diop AG, Ndiaye MM, Ndiaye IP, Gueye M, Mauferon JB, Kabre A.
    Dakar Med; 1990 Jun 01; 35(2):168-76. PubMed ID: 2135789
    [Abstract] [Full Text] [Related]

  • 28. Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.
    Colao A, Ferone D, Lastoria S, Cerbone G, Di Sarno A, Di Somma C, Lucci R, Lombardi G.
    Clin Endocrinol (Oxf); 2000 Apr 01; 52(4):437-45. PubMed ID: 10762286
    [Abstract] [Full Text] [Related]

  • 29. Hormone-secreting adrenal tumours cause severe hypertension and high rates of poor pregnancy outcome; a UK Obstetric Surveillance System study with case control comparisons.
    Quartermaine G, Lambert K, Rees K, Seed PT, Dhanjal MK, Knight M, McCance DR, Williamson C.
    BJOG; 2018 May 01; 125(6):719-727. PubMed ID: 28872770
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pituitary adenomas in childhood and adolescence. Clinical analysis of 10 cases.
    De Menis E, Visentin A, Billeci D, Tramontin P, Agostini S, Marton E, Conte N.
    J Endocrinol Invest; 2001 Feb 01; 24(2):92-7. PubMed ID: 11263478
    [Abstract] [Full Text] [Related]

  • 32. Prevalence and characteristics of sellar masses in the city of Al Ain, United Arab Emirates: 2010 to 2016.
    Aldahmani KM, Sreedharan J, Ismail MM, Philip J, Nair SC, Alfelasi M, Aziz W, Imran SA, Alkaabi J.
    Ann Saudi Med; 2020 Feb 01; 40(2):105-112. PubMed ID: 32241168
    [Abstract] [Full Text] [Related]

  • 33. [Prolactinoma].
    Krysiak R, Okopień B, Marek B, Szkróbka W.
    Przegl Lek; 2009 Feb 01; 66(4):198-205. PubMed ID: 19708510
    [Abstract] [Full Text] [Related]

  • 34. The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas.
    Di Sarno A, Landi ML, Marzullo P, Di Somma C, Pivonello R, Cerbone G, Lombardi G, Colao A.
    Clin Endocrinol (Oxf); 2000 Jul 01; 53(1):53-60. PubMed ID: 10931080
    [Abstract] [Full Text] [Related]

  • 35. Prolactinomas: Preconception and During Pregnancy.
    Zhang CD, Ioachimescu AG.
    Endocrinol Metab Clin North Am; 2024 Sep 01; 53(3):409-419. PubMed ID: 39084816
    [Abstract] [Full Text] [Related]

  • 36. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.
    Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A.
    J Clin Endocrinol Metab; 2006 Dec 01; 91(12):4769-75. PubMed ID: 16968795
    [Abstract] [Full Text] [Related]

  • 37. Clinical, Hormonal, and Neuroradiological Characteristics and Therapeutic Outcomes of Prolactinomas in Children and Adolescents at a Single Center.
    Yang A, Cho SY, Park H, Kim MS, Kong DS, Shin HJ, Jin DK.
    Front Endocrinol (Lausanne); 2020 Dec 01; 11():527. PubMed ID: 32849307
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Current diagnosis and treatment of hyperprolactinemia].
    Melgar V, Espinosa E, Sosa E, Rangel MJ, Cuenca D, Ramírez C, Mercado M.
    Rev Med Inst Mex Seguro Soc; 2016 Dec 01; 54(1):111-21. PubMed ID: 26820213
    [Abstract] [Full Text] [Related]

  • 40. Clinical and endocrine aspects of pituitary tumors.
    Zargar AH, Laway BA, Masoodi SR, Salahuddin M, Ganie MA, Bhat MH, Wani AI, Bashir MI.
    Saudi Med J; 2004 Oct 01; 25(10):1428-32. PubMed ID: 15494816
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.